Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Modalim


Contraindicated
Lack of data in pregnant women

Contraindicated
Manque de données
Modalim :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis
Origin UK
Manufacturer Sanofi Synthelabo Ltd
Origin UK
ATC C10AB08
Revision Date 30/01/2014

Your comment will appear shortly after approval

Modalim :

Revision Date : 30/01/2014


Effect Frequency
Abdominal pain Common
Alopecia Common
Cholelithiasis (Calculus biliary) (Gallstones) Not known
Cholestasis Not known
Creatine phosphokinase serum increased Not known
Cytolysis Not known
Diarrhoea (Diarrhea) Common
Dizziness Common
Dyspepsia Common
Eczema Not known
Erectile dysfunction Not known
Fatigue Common
Headache Common
Liver function test abnormal Not known
Myalgia Common
Myopathy Not known
Myositis Not known
Nausea Common
Photosensitivity reaction Not known
Pneumonitis Not known
Pruritus Not known
Pulmonary fibrosis Not known
Rhabdomyolysis Not known
Skin rash Common
Somnolence Common
Thrombocytopenia (Thrombopenia) Not known
Urticaria Not known
Vertigo Common
Vomiting Common

Different Units By MoH Code

Revision Date : 30/01/2014

Modalim Modalim Modalim Modalim Modalim Modalim

Modalim  MoH 1905 :
Form Capsule, hard
Packaging Blisters (Al/PVC)
Package Size Box of 28
Strength 100mg
NSSF ✘
Quarantine ✘
Reg. Number 38857
Submission date 01/01/1997
Registration Year 1997
Archived Date 2017


Price Comparison

● Country: KSA
● Package Size: 28
● Public Price: 47.65 SAR ( 1,126,446.00 LBP )
● Pack size unit used: 28
● Cost/Unit: 1,7018 SAR ( 23,640.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 28
● Medica Comments: Non Marketed
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info